Stifel Raises Price Target On Salix Pharmaceuticals, Ltd. On Possible Takeover
October 01, 2014 at 10:14 AM EDT
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) received a price target increase from $155 to $185 by Stifel, which maintained a Buy ...